Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Army
Dow
Argus Health
Harvard Business School
Novartis
AstraZeneca
Medtronic
Teva
Mallinckrodt

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,458,836

« Back to Dashboard

Which drugs does patent 6,458,836 protect, and when does it expire?

Patent 6,458,836 protects RESCULA and is included in one NDA.

This patent has twenty-one patent family members in eighteen countries.
Summary for Patent: 6,458,836
Title: Treatment of ocular hypertension and glaucoma
Abstract:Disclosed is treatment of ocular hypertension and glaucoma by long-term therapy with a prostaglandin related compound for eliminating or reducing potential iridic pigmentation. Composition useful for the treatment, and use of the prostaglandin related compound for producing the composition are also disclosed.
Inventor(s): Ueno; Ryuji (Potomac, MD)
Assignee: Sucampo, A.G. (Zug, CH)
Application Number:09/900,021
Patent Claim Types:
see list of patent claims
Use; Compound; Process;

Drugs Protected by US Patent 6,458,836

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sucampo Pharma Llc RESCULA unoprostone isopropyl SOLUTION/DROPS;OPHTHALMIC 021214-001 Aug 3, 2000 DISCN Yes No ➤ Sign Up ➤ Sign Up THE LONG TERM TREATMENT OF PROPHYLACTIC MANAGEMENT OF OCULAR HYPERTENSION AND GLAUCOMA ➤ Sign Up
Sucampo Pharma Llc RESCULA unoprostone isopropyl SOLUTION/DROPS;OPHTHALMIC 021214-001 Aug 3, 2000 DISCN Yes No ➤ Sign Up ➤ Sign Up METHOD OF TREATING OCULAR HYPERTENSION ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,458,836

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 029818 ➤ Sign Up
Australia 2001241143 ➤ Sign Up
Australia 4114301 ➤ Sign Up
Brazil 0109192 ➤ Sign Up
Canada 2402597 ➤ Sign Up
China 100506232 ➤ Sign Up
China 1429112 ➤ Sign Up
Czech Republic 20023092 ➤ Sign Up
European Patent Office 1272194 ➤ Sign Up
Hungary 0300391 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald
Baxter
Covington
Farmers Insurance
US Army
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot